These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1228283)

  • 1. [Use of rheopolyglucin in the treatment of obliterative atherosclerosis of the legs].
    Kokhan EP
    Klin Khir (1962); 1975 Nov; (11):65-6. PubMed ID: 1228283
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypervolemic treatment of the chronic obliterative arteriopathies of extremities.
    Brassai Z; Koválszki P; Pop GH; Kiss K; Olosz E
    Med Interne; 1986; 24(1):37-41. PubMed ID: 2422732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheodextran, vasodilating infusion and blood flow properties in patients with obliterative atherosclerosis of the lower extremities].
    Bulvas M; Linhart J
    Vnitr Lek; 1982 Sep; 28(9):902-7. PubMed ID: 6183828
    [No Abstract]   [Full Text] [Related]  

  • 4. [Testosterone treatment of obliterative arterial lesions in the legs].
    Hvidt V; Dohn K; Lund J; Nielsen J; Palm L
    Ugeskr Laeger; 1965 Sep; 127(36):1116-23. PubMed ID: 5869540
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hemorrhagic diathesis in a patient with obliterative arteriosclerosis during treatment with low-molecular dextran].
    Szmidt M; Rozniecki J; Religa H
    Pol Tyg Lek; 1972 Oct; 27(40):1566-8. PubMed ID: 5081828
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term effect of anticoagulants in obliterative arterial disease of the legs.
    Tillgren C; Lund F
    Scand J Clin Lab Invest Suppl; 1967; 99():184-6. PubMed ID: 6056920
    [No Abstract]   [Full Text] [Related]  

  • 7. [The use of vitamin B 15 in obliterative atherosclerosis of the lower lumbs].
    Afanas'eva LM
    Khirurgiia (Mosk); 1967 Dec; 43(12):36-8. PubMed ID: 5613253
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and hemodynamic effects of captopril in patients with arterial hypertension and obliterative arteriopathy of the legs].
    Bolognini G; Iezzi Biase G
    Clin Ter; 1986 Feb; 116(4):287-9. PubMed ID: 3516544
    [No Abstract]   [Full Text] [Related]  

  • 9. [Are vasodilators indicated in the treatment of obliterative arteriopathy of the lower limbs?].
    Cuypers Y; Baudinet V; Collignon P; Joris H; Kulbertus H; Rutten F
    Rev Med Liege; 1966 Apr; 21(8):185-8. PubMed ID: 5932052
    [No Abstract]   [Full Text] [Related]  

  • 10. [Combined treatment of aged patients with obliterative atherosclerosis of legs grade IV by intraarterial infusions and CO2-laser].
    Galimzianov FV; Belova AD
    Khirurgiia (Mosk); 1998; (12):18-21. PubMed ID: 9916427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
    Toth L
    Med Pregl; 1975; 28(3-4):181-3. PubMed ID: 1177851
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of etofibrate in the treatment of patients with hyperlipidemia and arteriosclerosis obliterans of the legs].
    Dembińska-Kieć A; Kostka-Trabka E; Grodzińska L; Bieroń K; Kedzior A; Basista M; Zmuda A; Trabka E; Sławiński M; Czarnecka B
    Pol Tyg Lek; 1987 Dec 21-28; 42(51-52):1643-8. PubMed ID: 3330798
    [No Abstract]   [Full Text] [Related]  

  • 13. [Status and correction of regional lipid metabolism in atherosclerosis obliterans of the arteries of the lower extremities].
    Ovchinnikov VA; Parakhoniak NV; Zubova TA
    Kardiologiia; 1987 Mar; 27(3):77-81. PubMed ID: 2438448
    [No Abstract]   [Full Text] [Related]  

  • 14. [Dextran 70 perfusion in treatment in arteriosclerosis obliterans].
    Brassai Z; Ferencz L; Vánesa G; Kovalszky P
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(3):231-60. PubMed ID: 18777
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
    Hunyi L
    Ther Hung; 1978; 26(2):77-80. PubMed ID: 684660
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of Sadamin on some blood clotting parameters and fibrinolysis in patients with obliterative arteriosclerosis of lower limb arteries].
    Kiersnowska B; Bielawiec M; Lukjan H; Korfel B; Rogowski F; Dowzyk W
    Pol Tyg Lek; 1973 Mar; 28(11):400-3. PubMed ID: 4694796
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of long-term pentoxifylline treatment on selected parameters of the fibrinolytic system in patients with arteriosclerosis obliterans of the legs].
    Berent H; Kancelarczyk WL; Zebrowski M; Uchman B
    Pol Tyg Lek; 1988 Jun; 43(24):776-8. PubMed ID: 3237518
    [No Abstract]   [Full Text] [Related]  

  • 18. [Considerations on the use of dextran of low molecular weight in the treatment of peripheral arteriopathy].
    Serra GC; Verlato R
    Acta Anaesthesiol; 1965; 16():Suppl 5:87-95. PubMed ID: 5899665
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of Probon for controlling ischaemic extremital pain in patients suffering from obliterative arteriosclerosis of advanced stage.
    Keller L; Landi A
    Ther Hung; 1979; 27(1):37-9. PubMed ID: 582859
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined fibrinolytic-clearing treatment in obliterative endareteritis in the aged patient].
    Baldoni E
    G Gerontol; 1967 Dec; 15(12):1477-89. PubMed ID: 5618944
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.